tiprankstipranks

Ali Behbahani Insider Profile

4 Followers
Ali Behbahani, Director at Nevro Corp, holds 4.51M shares in Black Diamond Therapeutics (Ticker: BDTX), holds 3.61M shares in MBX Biosciences, Inc. (Ticker: MBX), holds 1.09M shares in Korro Bio (Ticker: KRRO).
tipranks
Ali Behbahani

Ali Behbahani
Nevro Corp (NVRO)
Director

Ranked #93,379 out of 99,335 Corporate Insiders

Profitable Transactions

28%
5 out of 18 Profitable Transactions

Average Return

-26.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$761M
46.79%
12.56%
10.07%
8.45%
22.13% Others
A breakdown of Ali Behbahani's holdings

Insider Roles

NeueHealth Inc
(NEUE)
Ten Percent Owner
Mirum Pharmaceuticals
(MIRM)
Ten Percent Owner
Savara
(SVRA)
Ten Percent Owner
Monte Rosa Therapeutics
(GLUE)
Director, Ten Percent Owner
+13 other positions
Roles that Ali Behbahani holds in companies

Most Profitable Insider Trade

Stock:
Mirum Pharmaceuticals
(MIRM)
Rating:Informative Buy
Date:Jul 24, 2019 - Jul 24, 2020
Return:+47.80%
The most profitable trade made by Ali Behbahani

Ali Behbahani's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Nevro Corp
May 23, 2018
Director
Uninformative Buy
$22.80K
Adaptimmune Therapeutics
Jan 28, 2020
Director
Informative Buy
4.95M
$12.95M
Genocea Biosciences
May 26, 2022
Director, Ten Percent Owner
Informative Sell
711.52K
$0.00
Crispr Therapeutics AG
Aug 14, 2020
Director
Uninformative Buy
$12.76K
Regulus
May 09, 2019
Former 10% Owner
Informative Buy
1.23M
$2.87M
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
6.80M
$31.50M
Mirum Pharmaceuticals
Jun 15, 2023
Ten Percent Owner
Uninformative Buy
$95.52M
Black Diamond Therapeutics
Sep 20, 2024
Director
Uninformative Buy
14.37K
$10.95M
OYST
Oyster Point Pharma
Jan 04, 2023
Uninformative Sell
$0.00
AKUS
AKOUOS
Dec 02, 2022
Uninformative Sell
$0.00
Nkarta
Director
MTCR
Metacrine
Dec 27, 2021
Informative Sell
493.91K
$1.49M
Monte Rosa Therapeutics
Jun 30, 2021
Director, Ten Percent Owner
Uninformative Buy
$64.31M
CVRx
Dec 18, 2023
Director
Uninformative Buy
72.68
$4.27K
NeueHealth Inc
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
$355.95M
Minerva Surgical
Jun 14, 2022
Director
Uninformative Buy
120.00K
$699.35
Arcellx Inc
Jun 05, 2023
Director
Uninformative Buy
$36.98K
Savara
Jul 19, 2023
Ten Percent Owner
Informative Buy
1000.00K
$76.60M
Korro Bio
Apr 24, 2024
Director, Ten Percent Owner
Uninformative Buy
999.99K
$51.27M
MBX Biosciences, Inc.
Sep 17, 2024
Ten Percent Owner
Uninformative Buy
$58.70M
List of latest transactions for each holding click on a transaction to see Ali Behbahani's performance on stock

Ali Behbahani insider profile FAQ

What is the percentage of profitable transactions made by Ali Behbahani?
The percentage of profitable transactions made by Ali Behbahani is 28%.
    What is the average return per transaction made by Ali Behbahani?
    The average return per transaction made by Ali Behbahani is -26.70%.
      What stocks does Ali Behbahani hold?
      Ali Behbahani holds: NVRO, ADAP, GNCAQ, CRSP, RGLS, TRVI, MIRM, BDTX, OYST, AKUS, NKTX, MTCR, GLUE, CVRX, NEUE, UTRS, ACLX, SVRA, KRRO, MBX stocks.
        What was Ali Behbahani’s latest transaction?
        Ali Behbahani latest transaction was an Uninformative Buy of $14.37K.
          What was Ali Behbahani's most profitable transaction?
          Ali Behbahani’s most profitable transaction was an Informative Buy of MIRM stock on July 24, 2019. The return on the trade was 47.80%.
            What is Ali Behbahani's role in Nevro Corp?
            Ali Behbahani's role in Nevro Corp is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.